谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Randomized, Open-Label, Phase 3 Trial of Pembrolizumab Plus Epacadostat Versus Sunitinib or Pazopanib As First-Line Treatment for Metastatic Renal Cell Carcinoma (KEYNOTE-679/ECHO-302)

Primo N. Lara, Luis Villanueva,Carolina Ibanez,Mustafa Erman,Jae Lyun Lee,Daniel Heinrich,Oleg Nikolaevich Lipatov,Craig Gedye,Erhan Gokmen,Alejandro Acevedo,Andrey Semenov,Se Hoon Park,Rustem Airatovich Gafanov,Fatih Kose,Mark Jones, Xiaoqi Du,Mihaela Munteanu,Rodolfo Perini,Toni K. Choueiri,Robert J. Motzer

BMC Cancer（2024）

引用 0|浏览10
关键词
Renal cell carcinoma,Programmed death 1,PD-1,Indoleamine 2,3-deoxygenase 1,IDO1,Pembrolizumab,Epacadostat
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要